TrialLancet (London, England)2019

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study.

Pierre Van Damme et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.